Kishan Pandya
| Title | Professor Emeritus |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Medicine |
|---|
| Address | University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester NY 14642
|
|---|
|
|
|
| 1973 |
|
| Norwalk Hospital, "Outstanding Intern" Award
Norwalk, Connecticut, Affiliate with Yale University | | 1977 |
-
| 1978 | National Cancer Institute. University of Wisconsin, Wisconsin Clinical Cancer Center. Research and Training | | 1986 |
|
| American College of Physicians, "Fellow |
-
Chen Y, Pandya KJ, Hyrien O, Keng PC, Smudzin T, Anderson J, Qazi R, Smith B, Watson TJ, Feins RH, Johnstone DW. Preclinical and pilot clinical studies of docetaxel chemoradiation for Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Aug 1; 80(5):1358-64.
-
Ingersoll GL, Wasilewski A, Haller M, Pandya K, Bennett J, He H, Hoffmire C, Berry C. Effect of concord grape juice on chemotherapy-induced nausea and vomiting: results of a pilot study. Oncol Nurs Forum. 2010 Mar; 37(2):213-21.
-
Pandya KJ, Gajra A, Warsi GM, Argonza-Aviles E, Ericson SG, Wozniak AJ. Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer. Lung Cancer. 2010 Mar; 67(3):330-8.
-
Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T, Barton D, Novotny P. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol. 2009 Jun 10; 27(17):2831-7.
-
Shi Q, Wang XS, Mendoza TR, Pandya KJ, Cleeland CS. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage. 2009 Feb; 37(2):168-74.
-
Corbin K, Fisher S, Sahasrabudhe D, Pandya K, Brasacchio R, Constine LS. Five tumors over six years in eighth decade of life. Cancer Invest. 2008 Jul; 26(6):634-7.
-
Zhang H, Hyrien O, Pandya KJ, Keng PC, Chen Y. Tumor response kinetics after schedule-dependent paclitaxel chemoradiation treatment for inoperable non-small cell lung cancer: a model for low-dose chemotherapy radiosensitization. J Thorac Oncol. 2008 Jun; 3(6):563-8.
-
Brizel DM, Murphy BA, Rosenthal DI, Pandya KJ, Glück S, Brizel HE, Meredith RF, Berger D, Chen MG, Mendenhall W. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. J Clin Oncol. 2008 May 20; 26(15):2489-96.
-
Dudek AZ, Larson T, McCleod MJ, Schneider DJ, Dowell JE, Banerjee TK, Pandya KJ, Bromund JL, Chen R, Monberg MJ, Obasaju CK. Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer. J Thorac Oncol. 2008 Apr; 3(4):394-9.
-
Chen Y, Pandya KJ, Feins R, Johnstone DW, Watson T, Smudzin T, Keng PC. Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008 Jun 1; 71(2):407-13.
-
Pandya KJ, Dahlberg S, Hidalgo M, Cohen RB, Lee MW, Schiller JH, Johnson DH. A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500). J Thorac Oncol. 2007 Nov; 2(11):1036-41.
-
Pandya KJ, Hu P, Osborne CK, Falkson G, Tormey DC. Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185). Am J Clin Oncol. 2007 Apr; 30(2):113-25.
-
Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, Sweeney TJ, Banerjee TK, Flynn PJ. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005 Sep 3-9; 366(9488):818-24.
-
Pandya KJ, Thummala AR, Griggs JJ, Rosenblatt JD, Sahasrabudhe DM, Guttuso TJ, Morrow GR, Roscoe JA. Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat. 2004 Jan; 83(1):87-9.
-
Pandya KJ, Lefkopoulou M, Petrelli NJ, Vaughn DJ, Smith TJ, Harris JE, Haller DG. Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285). Oncology. 2004; 66(2):118-25.
-
Chen Y, Pandya K, Keng PC, Johnstone D, Li J, Lee YJ, Smudzin T, Okunieff P. Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines. Clin Cancer Res. 2003 Mar; 9(3):969-75.
-
Chen Y, Pandya K, Keng PP, Feins R, Raubertas R, Smudzin T, Rosenblatt J, Okunieff P. Schedule-dependent pulsed paclitaxel radiosensitization for thoracic malignancy. Am J Clin Oncol. 2001 Oct; 24(5):432-7.
-
Pandya KJ, Yeap BY, Weiner LM, Krook JE, Erban JK, Schinella RA, Davis TE. Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882). Am J Clin Oncol. 2001 Feb; 24(1):43-6.
-
Okunieff P, Hammond E, Grignon D, Langer C, Pajak TF, Ang K, Bruner DW, Travis E, Greven K, Guha A, Moulder J, Pollack A, Scarantino C, Sneige N, Watson J, Amin M, Bondy M, Chakravarti A, Chapman JD, Dicker A, Harris J, Koch W, Komaki R, Lange C, McBride W, Mitchell J, Milas L, Movsas B, Pandya K, Pienta K, Regine W, Ritter M, Rubin P, Safran H, Sauter E, Schell M, Stevens C, Trotti A, Vikram B. Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):75-87.
-
Kucuk O, Shevrin DH, Pandya KJ, Bonomi PD. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586). Am J Clin Oncol. 2000 Aug; 23(4):371-5.
-
Saphner T, Weller EA, Tormey DC, Pandya KJ, Falkson CI, Stewart J, Robert NJ. 21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literature. Am J Clin Oncol. 2000 Jun; 23(3):258-62.
-
Pandya KJ, Raubertas RF, Flynn PJ, Hynes HE, Rosenbluth RJ, Kirshner JJ, Pierce HI, Dragalin V, Morrow GR. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med. 2000 May 16; 132(10):788-93.
-
Simpson JF, Gray R, Dressler LG, Cobau CD, Falkson CI, Gilchrist KW, Pandya KJ, Page DL, Robert NJ. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol. 2000 May; 18(10):2059-69.
-
Kucuk O, Pandya KJ, Skeel RT, Hochster H, Abeloff MD. Phase II study of cisplatin and 5-fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185). Breast Cancer Res Treat. 1999 Sep; 57(2):201-6.
-
Woodlock TJ, Sahasrabudhe DM, Marquis DM, Greene D, Pandya KJ, McCune CS. Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alpha. J Immunother. 1999 May; 22(3):251-9.
-
Fetting JH, Gray R, Fairclough DL, Smith TJ, Margolin KA, Citron ML, Grove-Conrad M, Cella D, Pandya K, Robert N, Henderson IC, Osborne CK, Abeloff MD. Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study. J Clin Oncol. 1998 Jul; 16(7):2382-91.
-
Falkson G, Gelman RS, Pandya KJ, Osborne CK, Tormey D, Cummings FJ, Sledge GW, Abeloff MD. Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment. J Clin Oncol. 1998 May; 16(5):1669-76.
-
Collichio FA, Pandya K. Interferon alpha-2b and megestrol acetate in the treatment of advanced renal cell carcinoma: a phase II study. Am J Clin Oncol. 1998 Apr; 21(2):209-11.
-
Chang AY, Putt M, Pandya KJ, Harris J, Gelman R, Tormey DC, Falkson G. Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181). Am J Clin Oncol. 1998 Feb; 21(1):99-104.
-
Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med. 1997 Nov 1; 127(9):813-6.
-
Olson JE, Neuberg D, Pandya KJ, Richter MP, Solin LJ, Gilchrist KW, Tormey DC, Veeder M, Falkson G. The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer. 1997 Mar 15; 79(6):1138-49.
-
Clark JL, Küçük O, Neuberg DS, Benson AB, Taylor SG, Pandya KJ, Mansour EG, Douglass HO, Haller DG. Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1995 Aug; 18(4):318-24.
-
Collichio F, Pandya K. Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival. Oncology (Williston Park). 1994 Dec; 8(12):45-52.
-
Taylor KM, Feldstein ML, Skeel RT, Pandya KJ, Ng P, Carbone PP. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol. 1994 Sep; 12(9):1796-805.
-
Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994 Mar 3; 330(9):592-6.
-
Saphner T, Troxel AB, Tormey DC, Neuberg D, Robert NJ, Pandya KJ, Edmonson JH, Rosenbluth RJ, Abeloff MD. Phase II study of goserelin for patients with postmenopausal metastatic breast cancer. J Clin Oncol. 1993 Aug; 11(8):1529-35.
-
Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993 Jul 15; 119(2):121-6.
-
Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA, Gerstner JB, Pandya K, Ellefson RD. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA. 1993 Mar 10; 269(10):1262-7.
-
Morrow GR, Asbury R, Hammon S, Dobkin P, Caruso L, Pandya K, Rosenthal S. Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses, and clinical psychologists. Health Psychol. 1992; 11(4):250-6.
-
Robins HI, Neuberg DS, Benson AB, Pandya KJ, Tormey DC. Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group study. Invest New Drugs. 1990 Nov; 8(4):397-9.
-
Pandya KJ, Smith JL, Friedman A, Stilwell AM. Patterns of care of the elderly with cancer at a community hospital. Prog Clin Biol Res. 1990; 339:431-9.
-
Chang AY, Most C, Pandya KJ. Continuous intravenous infusion of 5-fluorouracil in the treatment of refractory breast cancer. Am J Clin Oncol. 1989 Oct; 12(5):453-5.
-
Chang AY, Bennett JM, Pandya KJ, Asbury R, McCune C. A study of aminoglutethemide and hydrocortisone in patients with advanced and refractory prostate carcinoma. Am J Clin Oncol. 1989 Aug; 12(4):358-60.
-
Pandya KJ, Kramar A, Asbury RF, Haller DG. A phase II study of spirogermanium in advanced large bowel cancer. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1988 Aug; 11(4):496-8.
-
Pandya KJ. Cancer control research in the Eastern Cooperative Oncology Group (ECOG). Prog Clin Biol Res. 1988; 278:111-7.
-
Willson JK, Knuiman MW, Skeel RT, Wolter JM, Pandya KJ, Falkson G, Chang YC. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study. Cancer Treat Rep. 1986 Oct; 70(10):1237-8.
-
Chang AY, Kuebler JP, Pandya KJ, Israel RH, Marshall BC, Tormey DC. Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids. Cancer. 1986 Jun 15; 57(12):2285-90.
-
Chang AY, Chuang C, Pandya KJ, Wierenga W. Chemoprevention of 7,12-dimethylbenz(alpha)anthracene (DMBA) induced rat mammary tumors by 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP). J Biol Response Mod. 1986 Apr; 5(2):112-6.
-
Pandya KJ, Chang AY, Qazi R, Rubins J, Asbury R. Combination chemotherapy for advanced colorectal cancer. A pilot study. Am J Clin Oncol. 1986 Feb; 9(1):31-4.
-
Chang AY, Kuebler JP, Tormey DC, Anderson S, Pandya KJ, Borden EC, Davis TE, Trump DL. Phase II evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancer. Cancer. 1986 Jan 1; 57(1):54-9.
-
Pandya KJ, Muggia FM, Skeel RT, Falkson G, Kaplan BM, Ettinger DS. A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot study. Am J Clin Oncol. 1985 Oct; 8(5):353-7.
-
Pandya KJ, McFadden ET, Kalish LA, Tormey DC, Taylor SG, Falkson G. A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer. A preliminary report. Cancer. 1985 Jan 1; 55(1):202-5.
-
Levin M, Pandya KJ, Khandekar JD, Horton J, Glick JH, Bennett JM, Muggia FM, Falkson G. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study. Cancer Treat Rep. 1984 Dec; 68(12):1511-2.
-
Pandya KJ, Chang YC. Cure of mediastinal seminoma. Ann Intern Med. 1982 Oct; 97(4):618.
-
Stephenson TF, Chang A, Pandya K, Ona F. Comparison of urographic and cholegraphic contrast enhanced CT liver scanning. Comput Radiol. 1982 Sep-Oct; 6(5):257-62.
-
Nassar VH, Jacobs J, Mirra SS, Pandya KJ, Schwartz S, Bennett JM. Burkitt cell leukemia following therapy for Hodgkin disease. Am J Hematol. 1982 Feb; 12(1):73-6.
-
Pandya KJ, Whitehead R, Crowley J, Citrin DL. Hyperaldosteronism associated with liver metastases. JAMA. 1980 Jul 11; 244(2):171-2.
-
Pandya KJ, Tormey DC, Davis TE, Falkson G, Banerjee TK, Crowley J. Phase II trial of 6-thioguanine in metastatic breast cancer. Cancer Treat Rep. 1980 Jan; 64(1):191-2.
|
Pandya's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
